Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Stories and Publications

New Chapters, Updates to the Assay Guidance Manual

Assay Guidance Manual coverIn July 2016, authors of the Assay Guidance Manual (AGM) ― a free, best-practices online resource devoted to the successful development of robust, early-stage drug discovery assays ― added two new chapters and revised two others. Updated quarterly, the AGM provides step-by-step guidance for high-throughput screening, lead optimization and early phases of regulated drug development projects.

The new chapters are:

  • Cellular Thermal Shift Assay (CETSA), in the In Vitro Cell-Based Assays section. The CETSA methodology provides a powerful and unprecedented approach to validate target engagement within the context of a living cell. This information provides guidance for adapting CETSA to a microplate format to support high-throughput screening and structure-activity relationship studies.
  • Interferences with Luciferase Reporter Enzymes, in the Assay Artifacts and Interferences section, focuses on artifacts associated with luciferase reporters, which are heavily used in a variety of primary and counter assays for drug discovery. The goal is to provide researchers with help developing and implementing the best possible primary and counter assays for high-throughput screens.

In addition, two chapters have been revised: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies and Cell Viability Assays. The next update is scheduled for October 2016.